Acción BNKL BIONIK LABORATORIES CORP.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Bionik Laboratories Corp.

Acciones

BNKL

US09074A2087

Mercado cerrado - OTC Markets
Otros sitios de cotización
 02:10:00 30/11/2023 		Varia. Cinco días. Varia. 1 de enero.
0,000001 USD -.--% Gráfico intradía de Bionik Laboratories Corp. -.--% -.--%
2023 Bionik Laboratories Corp. Anuncia Cambios Ejecutivos CI
2023 Bionik Laboratories Corp. presenta los resultados del ejercicio finalizado el 31 de marzo de 2023 CI

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Bionik Laboratories Corp. Announces Executive Changes
Bionik Laboratories Corp. Reports Earnings Results for the Full Year Ended March 31, 2023
Bionik Laboratories Corp. Auditor Raises 'Going Concern' Doubt
BIONIK LABORATORIES CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Other Events, Financial Statements and Exhibits (form 8-K)
Bionik Laboratories Expands Its Partnership with Lifepoint Health with the Installation of InMotion Robotic Devices at Four New Locations
Bionik Laboratories : Private Placement - Form 8-K
Bionik Laboratories Corp. Expands Its Partnership With Lifepoint Health With the Installation of InMotion® Robotic Devices at Four New Locations
Bionik Laboratories Corp. announced that it expects to receive $2 million in funding
Bionik Laboratories Reports a Significant Increase in Patient Volume at Its Acquired Rehabilitation Center in Florida
BIONIK LABORATORIES CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
BIONIK LABORATORIES CORP. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
BIONIK LABORATORIES CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
Bionik Laboratories Corp. announced that it has received $0.25 million in funding
Bionik Laboratories InMotion Robotic Devices on Display at the Korea International Medical and Hospital Equipment Show
BIONIK LABORATORIES CORP. : Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant, Unregistered Sale of Equity Securities, Financial Statements and Exhibits (form 8-K)
Bionik Laboratories Corp. announced that it has received $0.5 million in funding
Bionik Laboratories Reports Third Quarter Fiscal Year 2023 Financial Results
BIONIK LABORATORIES CORP. Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Bionik Laboratories Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Earnings Flash (BNKL) BIONIK LABORATORIES Posts Q3 Revenue $575.1M
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción BNKL
  4. Noticias Bionik Laboratories Corp.
  5. Otros idiomas